newsfilter
← Latest News
GlobeNewswire·

Radius Health Update on Abaloparatide Transdermal System

Company ascertained regulatory clarity for possible forward progression of abalo-TDS Additional and successful clinical trial would be required to advance towards an NDA filing New timeline for earliest possible abalo-TDS launch: 2H 2025 Based on reg